ArticleCureus2025
Spontaneous Involution of a Thyroid Nodule: When Nodules Can't Be Trusted.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A thyroid nodule (TN) is an abnormal growth within the thyroid gland, with a large prevalence in adults. They can be classified as benign or malignant based on their characteristics. Most nodules are non-palpable and require ultrasound and histopathological analysis for identification. This study reports a rare case of TN involution despite initially exhibiting malignant ultrasound characteristics. The patient presented with a cystic TN of 27.43 x 13.31 x 35.84 mm, initially classified as Thyroid Imaging Reporting and Data System (TIRADS)-2 and Bethesda II, which later transformed into a solid mass classified as TIRADS-5 and Bethesda I. Over time, the nodule demonstrated an 88% reduction in size to 5.93 x 6.34 x 10.17 mm, while maintaining a TIRADS-5 classification. Surveillance remains the primary management approach, with a follow-up scheduled for 2025. No lymphadenopathy was detected. The observed regression supports evidence that fine needle aspiration biopsy of cystic thyroid nodules may induce necrotic and fibrotic changes, potentially due to post-procedural hemorrhage leading to hematoma formation, tissue compression, and eventual involution. The primary focus of this case review is to contribute to the relatively limited research on TN involution and to briefly discuss the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.